Targeted Medical Pharma, Inc.
US ˙ OTCPK

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for William Shell. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Se højest rangerende insidere
Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at William Shell har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:TRGM / Targeted Medical Pharma, Inc. CEO & Chief Scientific Officer, Director, 10% Owner 162.907
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af William Shell. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb TRGM / Targeted Medical Pharma, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TRGM / Targeted Medical Pharma, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Maks		 Pris kl
Maks		 Maks
Fortjeneste ($)		 Maks. afkast (%)
2013-04-26 NONE Shell William 1.000 4,1500 1.000 4,1500 4.150 0
2013-04-25 NONE Shell William 3.000 4,0100 3.000 4,0100 12.030
2013-04-24 NONE Shell William 4.000 4,1500 4.000 4,1500 16.600
2013-04-23 NONE Shell William 9.500 4,1500 9.500 4,1500 39.425
2013-04-23 NONE Shell William 1.500 4,2500 1.500 4,2500 6.375
2013-04-22 NONE Shell William 2.500 4,2600 2.500 4,2600 10.650
2013-04-22 NONE Shell William 4.500 4,3200 4.500 4,3200 19.440
2013-04-19 NONE Shell William 1.000 4,3500 1.000 4,3500 4.350
2013-04-19 NONE Shell William 4.000 4,7300 4.000 4,7300 18.920
2013-04-18 NONE Shell William 13.500 4,9100 13.500 4,9100 66.285
2013-04-17 NONE Shell William 6.000 4,6500 6.000 4,6500 27.900
2013-04-17 NONE Shell William 30.500 4,5900 30.500 4,5900 139.995
2013-04-16 NONE Shell William 6.000 4,4700 6.000 4,4700 26.820
2013-04-16 NONE Shell William 32.000 4,4900 32.000 4,4900 143.680
2013-04-15 NONE Shell William 659 4,9700 659 4,9700 3.275
2013-04-15 NONE Shell William 39.200 4,5100 39.200 4,5100 176.792
2013-04-12 NONE Shell William 1.000 4,3800 1.000 4,3800 4.380
2013-04-12 NONE Shell William 16.200 4,0800 16.200 4,0800 66.096
2013-04-11 NONE Shell William 1.000 4,0000 1.000 4,0000 4.000
2013-04-11 NONE Shell William 14.000 3,9400 14.000 3,9400 55.160
2013-04-10 NONE Shell William 4.500 3,8500 4.500 3,8500 17.325
2013-04-10 NONE Shell William 12.149 2,9100 12.149 2,9100 35.354
2013-04-10 NONE Shell William 21.600 3,8200 21.600 3,8200 82.512
2013-04-09 NONE Shell William 11.000 2,3100 11.000 2,3100 25.410
2013-04-09 NONE Shell William 21.500 2,3200 21.500 2,3200 49.880
2013-04-08 NONE Shell William 1.000 2,1500 1.000 2,1500 2.150
2013-04-08 NONE Shell William 7.500 2,1400 7.500 2,1400 16.050
2013-04-05 NONE Shell William 4.000 2,1100 4.000 2,1100 8.440
2013-04-05 NONE Shell William 10.000 2,1000 10.000 2,1000 21.000
2013-04-04 NONE Shell William 3.500 2,0600 3.500 2,0600 7.210
2013-04-04 NONE Shell William 15.600 2,0700 15.600 2,0700 32.292
2013-04-03 NONE Shell William 1.000 2,0000 1.000 2,0000 2.000
2013-04-03 NONE Shell William 15.700 1,9900 15.700 1,9900 31.243
2013-04-02 NONE Shell William 1.000 1,9500 1.000 1,9500 1.950
2013-04-02 NONE Shell William 8.500 1,9200 8.500 1,9200 16.320
2013-04-01 NONE Shell William 3.000 1,7000 3.000 1,7000 5.100
2013-04-01 NONE Shell William 28.500 1,7500 28.500 1,7500 49.875
2013-03-28 NONE Shell William 1.000 1,5000 1.000 1,5000 1.500
2013-03-27 NONE Shell William 1.000 1,5000 1.000 1,5000 1.500
2013-03-26 NONE Shell William 3.000 1,5000 3.000 1,5000 4.500
2013-03-25 NONE Shell William 2.000 1,4500 2.000 1,4500 2.900
2013-03-25 NONE Shell William 5.000 1,4800 5.000 1,4800 7.400
2013-03-22 NONE Shell William 4.000 1,3900 4.000 1,3900 5.560
2013-03-18 NONE Shell William 1.500 1,5000 1.500 1,5000 2.250
2013-03-15 NONE Shell William 3.000 1,3800 3.000 1,3800 4.140
2013-03-14 NONE Shell William 2.000 1,2400 2.000 1,2400 2.480
2013-03-13 NONE Shell William 7.500 1,4500 7.500 1,4500 10.875
2013-03-12 NONE Shell William 1.500 1,3100 1.500 1,3100 1.965
2013-03-12 NONE Shell William 33.000 1,4100 33.000 1,4100 46.530
2013-03-11 NONE Shell William 5.000 1,0000 5.000 1,0000 5.000
2013-03-08 NONE Shell William 3.000 1,5000 3.000 1,5000 4.500
2013-02-07 NONE Shell William 3.500 2,1600 3.500 2,1600 7.560
2013-02-06 NONE Shell William 200 2,0000 200 2,0000 400
2013-01-18 NONE Shell William 1.000 2,3400 1.000 2,3400 2.340
2013-01-17 NONE Shell William 3.750 2,2200 3.750 2,2200 8.325
2013-01-11 NONE Shell William 1.500 2,3200 1.500 2,3200 3.480
2013-01-10 NONE Shell William 1.000 2,3000 1.000 2,3000 2.300
2013-01-09 NONE Shell William 500 2,3000 500 2,3000 1.150
2013-01-07 NONE Shell William 200 2,4500 200 2,4500 490
2013-01-03 NONE Shell William 2.000 2,1600 2.000 2,1600 4.320
2013-01-03 NONE Shell William 1.500 2,4700 1.500 2,4700 3.705
2012-12-28 NONE Shell William 500 2,7000 500 2,7000 1.350
2012-12-24 NONE Shell William 2.500 2,6100 2.500 2,6100 6.525
2012-12-14 NONE Shell William 2.700 4,5900 2.700 4,5900 12.393
2012-12-14 NONE Shell William 700 5,5400 700 5,5400 3.878
2012-12-13 NONE Shell William 4.000 4,8800 4.000 4,8800 19.520
2012-12-12 NONE Shell William 1.100 3,5000 1.100 3,5000 3.850
2012-12-12 NONE Shell William 700 4,7100 700 4,7100 3.297
2012-12-11 NONE Shell William 5.000 4,2100 5.000 4,2100 21.050
2012-12-10 NONE Shell William 1.000 3,3500 1.000 3,3500 3.350
2012-12-10 NONE Shell William 4.000 3,3100 4.000 3,3100 13.240
2012-12-07 NONE Shell William 5.000 3,5000 5.000 3,5000 17.500

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRGM / Targeted Medical Pharma, Inc. Insider Trades
Insidersalg TRGM / Targeted Medical Pharma, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TRGM / Targeted Medical Pharma, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier		 Rapporteret
Pris		 Justeret
Aktier		 Justeret
Pris		 Omkostningsgrundlag dage til
Min		 Pris kl
Min		 Max tab
Undgået ($)		 Max tab
Undgået (%)
2014-05-28 TRGM Shell William 2.000 0,6000 2.000 0,6000 1.200 323 0.0600 -1.080 -90,00
2014-05-27 TRGM Shell William 3.000 0,6500 3.000 0,6500 1.950
2014-04-10 TRGM Shell William 150.000 0,6000 150.000 0,6000 90.000
2013-09-13 TRGM Shell William 2.000 0,8400 2.000 0,8400 1.680

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

TRGM / Targeted Medical Pharma, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af William Shell som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om		 Del
Pris		 Tran
Værdi		 Tilbage
Værdi
2014-10-14 2014-07-24 4 TRGM Targeted Medical Pharma, Inc.
Common stock warrant 		A - Award 162.907 162.907
2014-05-28 2014-05-28 4 TRGM Targeted Medical Pharma, Inc.
Common Stock 		S - Sale -2.000 664.764 -0,30 0,60 -1.200 398.858
2014-05-27 2014-05-27 4 TRGM Targeted Medical Pharma, Inc.
Common Stock 		S - Sale -3.000 666.764 -0,45 0,65 -1.950 433.397
2014-04-10 2014-04-10 4 TRGM Targeted Medical Pharma, Inc.
Common Stock 		S - Sale -150.000 669.764 -18,30 0,60 -90.000 401.858
2013-12-02 2013-12-02 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		J - Other 236.967 5.352.377 4,63
2013-12-02 2013-12-02 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		J - Other 236.967 5.352.377 4,63
2013-12-02 2013-12-02 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		J - Other 177.725 5.530.102 3,32
2013-12-02 2013-12-02 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		J - Other 236.967 5.767.069 4,29
2013-12-02 2013-12-02 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		J - Other 296.209 6.063.278 5,14
2013-11-20 2013-11-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other -229.674 5.115.381 -4,30
2013-11-20 2013-11-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other 130.709 3.553.457 3,82
2013-11-20 2013-11-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other 98.965 819.764 13,73
2013-11-20 2013-11-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		G - Gift -24.999 5.345.055 -0,47
2013-09-20 2013-09-13 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		S - Sale -2.000 208.000 -0,95 0,84 -1.680 174.720
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other -584.795 66.259 -89,82
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other -99.000 0 -100,00
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other -8.342.748 722.485 -92,03
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other 3.422.748 3.422.748
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other 300.000 720.799 71,29
2013-09-20 2013-09-11 4 TRGM Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		W - Other 5.303.795 5.370.054 8.004,64
2013-07-23 2013-06-04 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		C - Conversion 584.795 639.954 1.060,20
2013-07-23 2013-04-26 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 420.799 0,24 4,15 4.150 1.746.316
2013-07-23 2013-04-25 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.000 419.799 0,72 4,01 12.030 1.683.394
2013-07-23 2013-04-24 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 416.799 0,97 4,15 16.600 1.729.716
2013-07-23 2013-04-23 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.500 55.159 2,80 4,25 6.375 234.426
2013-07-23 2013-04-23 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 9.500 412.799 2,36 4,15 39.425 1.713.116
2013-07-23 2013-04-22 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.500 403.299 1,13 4,32 19.440 1.742.252
2013-07-23 2013-04-22 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.500 53.659 4,89 4,26 10.650 228.587
2013-07-23 2013-04-19 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 398.799 1,01 4,73 18.920 1.886.319
2013-07-23 2013-04-19 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 51.159 1,99 4,35 4.350 222.542
2013-07-23 2013-04-18 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 13.500 394.799 3,54 4,91 66.285 1.938.463
2013-07-23 2013-04-17 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 30.500 381.299 8,69 4,59 139.995 1.750.162
2013-07-23 2013-04-17 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 6.000 50.159 13,59 4,65 27.900 233.239
2013-07-23 2013-04-16 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 32.000 350.799 10,04 4,49 143.680 1.575.088
2013-07-23 2013-04-16 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 6.000 44.159 15,72 4,47 26.820 197.391
2013-07-23 2013-04-15 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 39.200 318.799 14,02 4,51 176.792 1.437.783
2013-07-23 2013-04-15 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 659 38.159 1,76 4,97 3.275 189.650
2013-07-23 2013-04-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 16.200 279.599 6,15 4,08 66.096 1.140.764
2013-07-23 2013-04-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 37.500 2,74 4,38 4.380 164.250
2013-07-23 2013-04-11 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 14.000 263.399 5,61 3,94 55.160 1.037.792
2013-07-23 2013-04-11 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 36.500 2,82 4,00 4.000 146.000
2013-07-23 2013-04-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 21.600 237.250 10,02 3,82 82.512 906.295
2013-07-23 2013-04-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 12.149 249.399 5,12 2,91 35.354 725.751
2013-07-23 2013-04-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.500 35.500 14,52 3,85 17.325 136.675
2013-07-23 2013-04-09 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 21.500 215.650 11,07 2,32 49.880 500.308
2013-07-23 2013-04-09 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 11.000 31.000 55,00 2,31 25.410 71.610
2013-07-23 2013-04-08 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 7.500 194.150 4,02 2,14 16.050 415.481
2013-07-23 2013-04-08 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 20.000 5,26 2,15 2.150 43.000
2013-07-23 2013-04-05 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 10.000 186.650 5,66 2,10 21.000 391.965
2013-07-23 2013-04-05 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 19.000 26,67 2,11 8.440 40.090
2013-07-23 2013-03-07 4 NONE Targeted Medical Pharma, Inc.
Option to Purchase Common Stock 		A - Award 150.000 150.000
2013-07-23 2012-07-05 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 95.000 95.000
2013-07-23 2012-06-21 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 220.000 220.000
2013-07-23 2012-06-07 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 175.000 175.000
2013-07-23 2012-05-25 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 190.000 190.000
2013-07-23 2012-05-24 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 220.000 220.000
2013-07-23 2012-05-10 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 110.000 110.000
2013-07-23 2012-05-02 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 150.000 150.000
2013-07-23 2012-04-26 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 200.000 200.000
2013-07-23 2012-04-19 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 100.000 100.000
2013-07-23 2012-04-11 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 250.000 250.000
2013-07-23 2013-01-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 29.400 3,52 2,30 2.300 67.620
2013-07-23 2013-01-09 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 500 28.400 1,79 2,30 1.150 65.320
2013-07-23 2013-01-07 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 200 27.900 0,72 2,45 490 68.355
2013-07-23 2013-01-03 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.500 27.700 5,73 2,47 3.705 68.419
2013-07-23 2013-01-03 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.000 3.000 200,00 2,16 4.320 6.480
2013-07-23 2012-12-28 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 500 26.200 1,95 2,70 1.350 70.740
2013-07-23 2012-12-24 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.500 25.700 10,78 2,61 6.525 67.077
2013-07-23 2012-12-14 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 700 20.500 3,54 5,54 3.878 113.570
2013-07-23 2012-12-14 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.700 23.200 13,17 4,59 12.393 106.488
2013-07-23 2012-12-13 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 19.800 25,32 4,88 19.520 96.624
2013-07-23 2012-12-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 700 14.700 5,00 4,71 3.297 69.237
2013-07-23 2012-12-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.100 15.800 7,48 3,50 3.850 55.300
2013-07-23 2012-12-11 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 5.000 14.000 55,56 4,21 21.050 58.940
2013-07-23 2012-12-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 9.000 80,00 3,31 13.240 29.790
2013-07-23 2012-12-10 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 1.000 3,35 3.350 3.350
2013-07-23 2012-12-07 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 5.000 5.000 3,50 17.500 17.500
2013-07-23 2013-04-04 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 15.600 176.650 9,69 2,07 32.292 365.666
2013-07-23 2013-04-04 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.500 15.000 30,43 2,06 7.210 30.900
2013-07-23 2013-04-03 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 15.700 161.050 10,80 1,99 31.243 320.490
2013-07-23 2013-04-03 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 11.500 9,52 2,00 2.000 23.000
2013-07-23 2013-04-02 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 8.500 145.350 6,21 1,92 16.320 279.072
2013-07-23 2013-04-02 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 10.500 10,53 1,95 1.950 20.475
2013-07-23 2013-04-01 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 28.500 136.850 26,30 1,75 49.875 239.488
2013-07-23 2013-04-01 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.000 9.500 46,15 1,70 5.100 16.150
2013-07-23 2013-03-28 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 108.350 0,93 1,50 1.500 162.525
2013-07-23 2013-03-27 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 107.350 0,94 1,50 1.500 161.025
2013-07-23 2013-03-26 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.000 106.350 2,90 1,50 4.500 159.525
2013-07-23 2013-03-25 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 5.000 103.350 5,08 1,48 7.400 152.958
2013-07-23 2013-03-25 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.000 6.500 44,44 1,45 2.900 9.425
2013-07-23 2013-03-22 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 4.000 98.350 4,24 1,39 5.560 136.706
2013-07-23 2013-03-18 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.500 94.350 1,62 1,50 2.250 141.525
2013-07-23 2013-03-15 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.000 92.850 3,34 1,38 4.140 128.133
2013-07-23 2013-03-14 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 2.000 89.850 2,28 1,24 2.480 111.414
2013-07-23 2013-03-13 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 7.500 87.850 9,33 1,45 10.875 127.382
2013-07-23 2013-03-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 33.000 80.350 69,69 1,41 46.530 113.294
2013-07-23 2013-03-12 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.500 4.500 50,00 1,31 1.965 5.895
2013-07-23 2013-03-11 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 5.000 47.350 11,81 1,00 5.000 47.350
2013-07-23 2013-03-08 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.000 42.350 7,62 1,50 4.500 63.525
2013-07-23 2013-02-07 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.500 39.350 9,76 2,16 7.560 84.996
2013-07-23 2013-02-06 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 200 35.850 0,56 2,00 400 71.700
2013-07-23 2013-01-18 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.000 35.650 2,89 2,34 2.340 83.421
2013-07-23 2013-01-17 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 3.750 34.650 12,14 2,22 8.325 76.923
2013-07-23 2013-01-16 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		G - Gift -300.000 9.065.233 -3,20
2013-07-23 2013-01-16 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		G - Gift 200.000 200.000
2013-07-23 2013-01-16 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		G - Gift 99.000 99.000
2013-07-23 2013-01-11 4 NONE Targeted Medical Pharma, Inc.
Common Stock, $.001 par value per share 		P - Purchase 1.500 30.900 5,10 2,32 3.480 71.688
2012-06-26 2012-06-22 4 NONE Targeted Medical Pharma, Inc.
Options to Purchase Common Stock 		A - Award 100.000 100.000
2012-06-14 2012-06-08 4 NONE Targeted Medical Pharma, Inc.
Common Stock 		G - Gift -53.818 9.365.233 -0,57
2012-06-14 2012-03-28 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 71.006 44.739 -270,32
2012-06-14 2012-03-15 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 22.189 22.189
2012-06-14 2012-02-29 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 71.006 71.006
2012-06-14 2012-02-15 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 59.172 59.172
2012-06-14 2012-02-01 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 73.964 73.964
2012-06-14 2012-01-31 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 59.172 59.172
2012-06-14 2012-01-19 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 29.586 29.586
2012-06-14 2012-01-18 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 7.396 7.396
2012-06-14 2012-01-04 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 8.876 8.876
2012-06-14 2011-12-07 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 34.024 30.024 -850,60
2012-06-14 2011-11-22 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 41.420 41.420
2012-06-14 2011-11-08 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 35.503 35.503
2012-06-14 2011-10-20 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 36.982 36.982
2012-06-14 2011-10-17 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 50.296 50.296
2012-06-14 2011-08-19 4 NONE Targeted Medical Pharma, Inc.
Warrants to Purchase Common Stock 		A - Award 140.000 140.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)